International Journal of Oncological Nursing and Practices

Editors Overview

ijonnp maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue

Cancer Immunotherapy

Abstract Submission Deadline : November 30, 2023

Manuscript Submission Deadline : December 25, 2023

Special Issue Description

Immunotherapy is a form of cancer treatment that makes use of the patient’s immune system. Immunotherapy can alter or enhance the immune system’s functioning to help it identify and combat cancer cells. Knowing how immunotherapy works and what to anticipate can frequently help you be ready for treatment and make knowledgeable decisions about your care if your treatment plan includes it. Monoclonal antibodies, Checkpoint Inhibitors. Checkpoint inhibitors, Cytokines, Vaccines to treat cancer, CAR T-cell therapy, etc. are the various types of cancer immunotherapy. Lowered blood counts brought on by immunotherapy may result in bleeding, anemia, and other issues. Lungs. Immune checkpoint inhibitors have the potential to result in pneumonitis, an inflammation of the lungs that can lead to a cough or breathing difficulties. Although uncommon, pneumonitis can be dangerous. In this special issue, we are inviting you to submit your research work focused on medical oncology, cell culture, gene therapy, and immunotherapy for the international journal of oncological Nursing.


CAR T-cell
Checkpoint inhibitors

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals: